PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Swoboda, A.S.* ; Arfelli, V.C.* ; Danese, A. ; Windisch, R.* ; Kerbs, P.* ; Redondo Monte, E.* ; Bagnoli, J.W.* ; Chen-Wichmann, L.* ; Caroleo, A.* ; Cusan, M.* ; Krebs, S.* ; Blum, H.* ; Sterr, M. ; Enard, W.* ; Herold, T.* ; Colomé-Tatché, M. ; Wichmann, C.* ; Greif, P.A.*

CSF3R T618I collaborates With RUNX1-RUNX1T1 to expand hematopoietic progenitors and sensitizes to GLI inhibition.

Hemasphere 7:e958 (2023)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Activating colony-stimulating factor-3 receptor gene (CSF3R) mutations are recurrent in acute myeloid leukemia (AML) with t(8;21) translocation. However, the nature of oncogenic collaboration between alterations of CSF3R and the t(8;21) associated RUNX1-RUNX1T1 fusion remains unclear. In CD34+ hematopoietic stem and progenitor cells from healthy donors, double oncogene expression led to a clonal advantage, increased self-renewal potential, and blast-like morphology and distinct immunophenotype. Gene expression profiling revealed hedgehog signaling as a potential mechanism, with upregulation of GLI2 constituting a putative pharmacological target. Both primary hematopoietic cells and the t(8;21) positive AML cell line SKNO-1 showed increased sensitivity to the GLI inhibitor GANT61 when expressing CSF3R T618I. Our findings suggest that during leukemogenesis, the RUNX1-RUNXT1 fusion and CSF3R mutation act in a synergistic manner to alter hedgehog signaling, which can be exploited therapeutically.
Impact Factor
Scopus SNIP
Altmetric
9.100
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Acute Myeloid-leukemia; Self-renewal; Aml1-eto; Mutations; Expression; Dasatinib; Cells; Kinase; Cebpa; Jak2
Language english
Publication Year 2023
HGF-reported in Year 2023
ISSN (print) / ISBN 2572-9241
e-ISSN 2572-9241
Journal Hemasphere
Quellenangaben Volume: 7, Issue: 10, Pages: , Article Number: e958 Supplement: ,
Publisher Wolters Kluwer Health
Publishing Place Two Commerce Sq, 2001 Market St, Philadelphia, Pa 19103 Usa
Reviewing status Peer reviewed
Institute(s) Institute of Computational Biology (ICB)
Institute of Diabetes and Regeneration Research (IDR)
POF-Topic(s) 30205 - Bioengineering and Digital Health
90000 - German Center for Diabetes Research
Research field(s) Enabling and Novel Technologies
Helmholtz Diabetes Center
PSP Element(s) G-503800-001
G-501900-231
G-554200-001
Grants German Research Foundation (DFG)
"Initiative and Networking Fund" of the Helmholtz Association
Munich Clinician Scientist Program (MCSP) Advanced Track
Wilhelm Sander-Stiftung (Forderantrag)
German Research Foundation (DFG) within the Collaborative Research Centre (SFB) 1243 "Cancer Evolution"
DOI 10.1097/HS9.0000000000000958
WOS ID 001082929000001
Scopus ID 85175167634
PubMed ID 37841755
Erfassungsdatum 2023-11-28
[➜Report correction]